United Way Mumbai (UWM) has worked with 7,00,000+ unaware vulnerable community groups such as commercial sex workers, truck drivers, scrap yard workers, barbers, pregnant women, women in child bearing ages, etc. across Mumbai since 2010 for education, prevention and treatment of Hepatitis B and C. UWM through its projects ‘Yuvroshni’ (‘yuva’ meaning youth and ‘roshni’ meaning light) and ‘Pahal; (initiative) and SEHAT (health), brings together key stakeholders such as public healthcare systems, municipal corporations, college youth, education institutions, local community based organisations, corporates and the community to ensure a sustained and far reaching impact. Youth, the integral stakeholders played a pivotal role in the widespread sensitization of vulnerable community groups.
Aligning to the findings of a global survey commissioned by the World Hepatitis Alliance, United Way Mumbai’s efforts have focused on addressing four major barriers to diagnosis Hepatitis B and C
United Way Mumbai (UWM) is a part of 130+ year old United Way movement spanning 41 countries across the world. Our mission is to improve lives by mobilizing the caring power of communities to advance the common good. We work closely with a network of 400+ NGOs and a large number of corporates for their CSR programmes, workplace giving campaigns and other events. This includes designing of CSR policy and strategies, due diligence of NGO partners, programme implementation, employee volunteering, impact assessments and financial and programmatic reporting. Over the past 16 years, we have partnered with over 300 companies and over 1, 00,000 individual donors investing close to INR 3120 million for community development projects.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close